Independent Director · ArriVent BioPharma, Inc. (AVBP)

Merdad Parsey, M.D., Ph.D director compensation at ArriVent: $509K

Fiscal year 2025 director compensation for Merdad Parsey, M.D., Ph.D at ArriVent BioPharma, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Merdad Parsey, M.D., Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Merdad’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Merdad Parsey, M.D., Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

ArriVent BioPharma Director Compensation Table · the one fiscal year held
In US dollars, as ArriVent BioPharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$39,375$0$469,744—$509,119

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ArriVent BioPharma, Inc. DEF 14A filed April 28, 2026, accession 0001104659-26-050337, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ArriVent BioPharma, Inc. filed document, accession 0001104659-26-050337. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the ArriVent BioPharma Board Governance Report

$509,119 Merdad Parsey, M.D., Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

ArriVent BioPharma pays directors a $45,000 cash retainer and $235,000 in Options.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance

The rest of the ArriVent BioPharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Chris W. NoletIndependent Director$343,525
James Healy, M.D., Ph.DIndependent Director$0
John Hohneker, M.DIndependent Director$505,006
Kristine PetersonLead Independent Director$395,820
Stuart Lutzker, M.D., Ph.DDirector—
Zhengbin (Bing) Yao, Ph.DChair of the Board—

The full ArriVent BioPharma compensation record

free company brief

This page is one director within ArriVent BioPharma's record. The company brief lists every named executive and director, each linking to their own page.

Order AVBP

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report